Quick answers
- What is Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic, unspecified form / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) used for?
- The FDA-approved label (InterSol, Fenwal, Inc., June 27, 2025) says: “6B7800S 12x 800 mL Rx only Store at Controlled Room Temperature. Protect from freezing. Avoid excessive heat. Definition of "Controlled Room Temperature": "A temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F); that results in a mean kinetic temperature calculated to be not more than 25°C …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic, unspecified form / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) have a boxed warning?
- No. None of the 3 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic, unspecified form / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate)?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic, unspecified form / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic, unspecified form / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate)?
- 1 company lists prescription products of Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic, unspecified form / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) in the FDA NDC Directory, including Fenwal, Inc..
What Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic, unspecified form / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
6B7800S 12x 800 mL Rx only Store at Controlled Room Temperature. Protect from freezing. Avoid excessive heat. Definition of "Controlled Room Temperature": "A temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F); that results in a mean kinetic temperature calculated to be not more than 25°C …
— FDA label: InterSol, Fenwal, Inc., effective June 27, 2025. Read the full label on DailyMed →
The FDA has 3 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 3 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Solution |
|---|---|
| Route | Intravenous |
| Prescription products | 3 in the FDA NDC Directory |
| Brand names | Intersol, Solucion Intersol |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Fenwal, Inc.3 products
FDA approval history
No Drugs@FDA application is linked to these products.
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| SPL set ID of the quoted label | 17dec820-1b57-4ac9-82a8-419cab664a2f |
|---|---|
| FDA labels (SPL) | 3 |
| Active ingredients (FDA) | SODIUM ACETATE / SODIUM CHLORIDE / SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM / SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE / TRISODIUM CITRATE DIHYDRATE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — InterSol, Fenwal, Inc., effective June 27, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →